Dr. Ysselstein is the Director of Cell and Molecular Pharmacology at Vanqua. Prior to joining Vanqua, Dan worked at Northwestern University with Vanqua Co-Founder Dimitri Krainc. His work focused on using induced pluripotent stem cell-derived models to expand the understanding of basic CNS diseases including Parkinson’s and Frontal Temporal Dementia. Previously, Dan worked on alpha synuclein structural biology where he identified a new therapeutic approach to modulate alpha synuclein misfolding
This person is not in the org chart